Post-polio Syndrome Clinical Trial
Official title:
Comparison of Activity and Fatigue of the Respiratory Muscles and Pulmonary Characteristics Between Post-Polio Patients and Healthy Controls: A Pilot Study
Verified date | February 2017 |
Source | Hadassah Medical Organization |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: Early diagnosis of respiratory impairment in Post-Polio (PPS) patients may delay
respiratory decline and future need of invasive respiratory aids.
Objectives: To compare pulmonary function measures, maximal respiratory pressure and
activity levels and fatigue of respiratory muscles between patients with PPS and healthy
controls.
Design: Cross-sectional study. Setting: Hadassah physical medicine and rehabilitation
department, Jerusalem. Patients: Patients with PPS (N=12; 6 males; age 62.1±11.6 years) able
to walk for 6 minutes without human assistance; age-matched healthy subjects (N=12; 4 males;
age 62.2±6.5 years).
Intervention: None. Measurements: A body plethysmograph was used to quantify forced
expiratory volume in the first second of a forced expiratory maneuver, vital capacity, slow
vital capacity, Residual Volume (RV), Total Lung Capacity (TLC), and Thoracic Gas Volume
(TGV). Also, RV to TLC ratio is calculated. A manometer was used to measure Maximal
Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP). A spirometer was used to
measure Maximal Voluntary Ventilation (MVV). Surface electromyography (sEMG) recorded
diaphragmatic muscle activity during rest and while performing MVV.
Status | Completed |
Enrollment | 24 |
Est. completion date | January 2016 |
Est. primary completion date | January 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Diagnosed with post-polio syndrome - Able to walk for 6 minutes, with or without walking aids and orthotics but without human assistance Exclusion Criteria: - Any neurological or orthopedic condition, unrelated to post-polio syndrome |
Country | Name | City | State |
---|---|---|---|
Israel | Hadassah Medical Center | Jerusalem |
Lead Sponsor | Collaborator |
---|---|
Hadassah Medical Organization |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Median frequency of electromyography | measure related to fatigue measured during maximal voluntary ventilation | Two hours | |
Secondary | Pulmonary function | Measured using a body plethysmograph | Two hours | |
Secondary | maximal inspiratory/expiratory pressures | Measured using ahand-held portable, digital manometer | Two hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02176863 -
Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03561623 -
Spinal Cord Gray Matter Imaging in Post Polio Syndrome
|
||
Completed |
NCT02815878 -
Enhance Wellness for Individuals With Long-Term Physical Disabilities
|
N/A | |
Recruiting |
NCT05644522 -
Nomad P-KAFO Study
|
N/A | |
Completed |
NCT02801071 -
L-Citrulline in Patients With Post-Polio Syndrome
|
Phase 3 | |
Completed |
NCT01537575 -
Intravenous Immunoglobulins for Post-Polio Syndrome
|
Phase 3 | |
Active, not recruiting |
NCT02089880 -
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
|
N/A | |
Completed |
NCT01402570 -
Glutathione and Health With Post-Polio Syndrome
|
N/A | |
Completed |
NCT00231439 -
Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)
|
Phase 2/Phase 3 |